CLINICAL_TRIALS
trial_result
· 2010-04-28
Clinical Trial Update: Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis [Phase 3]
Summary
Phase 3 clinical trial update reporting safety and efficacy results for adalimumab in patients with active ankylosing spondylitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED | Results posted: 2010-04-28